These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7515146)

  • 1. Aprotinin to decrease bleeding in cardiac surgery.
    Med Lett Drugs Ther; 1994 Jun; 36(924):50-1. PubMed ID: 7515146
    [No Abstract]   [Full Text] [Related]  

  • 2. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Beattie WS; Karkouti K
    Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
    [No Abstract]   [Full Text] [Related]  

  • 3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current antifibrinolytic therapy for coronary artery revascularization.
    Trudell J; McMurdy N
    AANA J; 2008 Apr; 76(2):121-4. PubMed ID: 18478817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin and lysine analogues in high-risk cardiac surgery.
    Porte RJ; Mallette SV; Burroughs AK
    N Engl J Med; 2008 Sep; 359(11):1181; author reply 1181-2. PubMed ID: 18784112
    [No Abstract]   [Full Text] [Related]  

  • 6. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned in antifibrinolytic therapy: The BART trial.
    Murkin JM
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):127-31. PubMed ID: 19622534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.
    Gill JB; Rosenstein A
    J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
    Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
    Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery.
    Ranucci M; Castelvecchio S; Romitti F; Isgrò G; Ballotta A; Conti D
    Acta Anaesthesiol Scand; 2009 May; 53(5):573-80. PubMed ID: 19173686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin: 1 year on.
    Dietrich W
    Curr Opin Anaesthesiol; 2009 Feb; 22(1):121-7. PubMed ID: 19295302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of the bleeding tendency of preoperative aspirin after aortocoronary bypass grafting.
    Bidstrup BP; Hunt BJ; Sheikh S; Parratt RN; Bidstrup JM; Sapsford RN
    Ann Thorac Surg; 2000 Feb; 69(2):541-7. PubMed ID: 10735695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and management of bleeding during cardiac surgery.
    Levy JH; Tanaka KA; Steiner ME
    Curr Hematol Rep; 2005 Sep; 4(5):368-72. PubMed ID: 16131437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.
    Brown JR; Birkmeyer NJ; O'Connor GT
    Circulation; 2007 Jun; 115(22):2801-13. PubMed ID: 17533182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Yasim A; Aşik R; Atahan E
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should aprotinin be reconsidered for use in pediatric surgery?
    Goobie S
    Paediatr Anaesth; 2014 Feb; 24(2):137-40. PubMed ID: 24387146
    [No Abstract]   [Full Text] [Related]  

  • 19. Aprotinin for prophylaxis of blood loss.
    McCarthy MW; Coley KC
    Ann Pharmacother; 1994 Nov; 28(11):1246-8. PubMed ID: 7531517
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifibrinolytics in liver transplantation.
    Groenland TH; Porte RJ
    Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.